Literature DB >> 648934

Further evidence of a primary mucosal defect in coeliac disease.

H J Cornell, C J Rolles.   

Abstract

Subfractions of fraction 9, obtained from a peptic-tryptic-pancreatinic digest of wheat gliadin, were subjected to in vitro mucosal digestion and the filtrates examined for residual peptides. Small-intestinal mucosa from four groups of individuals were studied-eight patients with coeliac disease in remission; eight healthy controls; nine first degree relatives of patients with coeliac disease, and six children with recurrent diarrhoea investigated for possible coeliac disease, but in whom the diagnosis was excluded. The highest amounts of residual peptides (measured by scanning densitometer) were detected after digestion with mucosa from patients with coeliac disease and the lowest amounts with the control groups. The results obtained with the group of relatives fell between those of the coeliac disease and control groups, while the recurrent diarrhoea group overlapped the relatives and controls. The residual peptides were derived chiefly from the B-type subfractions of subfractions 1 and 2, obtained by ion-exchange chromatography of fraction 9. These subfractions are rich in glutamine/glutamic acid and proline and have a molecular weight (apparent) of not greater than 1500 Daltons. The results lend further support to the hypothesis of an enzyme deficiency in coeliac disease. A partial enzyme deficiency may exist in some first-degree relatives and in some children with recurrent diarrhoea but with histology of the small intestine within normal limits. HLA-B8 antigen is not correlated with this deficiency, but, when the two factors are associated, they could be related to the manifestation and severity of coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 648934      PMCID: PMC1411936          DOI: 10.1136/gut.19.4.253

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Circulating antibodies to wheat gliadin fractions in coeliac disease.

Authors:  H J Cornell
Journal:  Arch Dis Child       Date:  1974-06       Impact factor: 3.791

3.  Toxicity of wheat gliadin fractions in coeliac disease.

Authors:  R R Townley; H J Cornell; P S Bhathal; J D Mitchell
Journal:  Lancet       Date:  1973-06-16       Impact factor: 79.321

4.  Histocompatibility antigens associated with adult coeliac disease.

Authors:  P L Stokes; P Asquith; G K Holmes; P Mackintosh; W T Cooke
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

5.  Skin test for coeliac disease using a subfraction of gluten.

Authors:  B S Anand; S C Truelove; R E Offord
Journal:  Lancet       Date:  1977-01-15       Impact factor: 79.321

6.  Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten.

Authors:  K Sikora; B S Anand; S C Truelove; P J Ciclitira; R E Offord
Journal:  Lancet       Date:  1976-08-21       Impact factor: 79.321

7.  HLA-DW3 associated with coeliac disease.

Authors:  J J Keuning; A S Peña; A van Leeuwen; J P van Hooff; J J va Rood
Journal:  Lancet       Date:  1976-03-06       Impact factor: 79.321

8.  An alternative mechanism for gluten toxicity in coeliac disease.

Authors:  M M Weiser; A P Douglas
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

9.  Non-specific cytotoxicity of wheat gliadin components towards cultured human cells.

Authors:  D A Hudson; H J Cornell; D R Purdham; C J Rolles
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766

View more
  5 in total

1.  Sequential morphologic and biochemical studies of naturally occurring wheat-sensitive enteropathy in Irish setter dogs.

Authors:  R M Batt; L McLean; M W Carter
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

2.  Breakdown of gliadin peptides by intestinal brush borders from coeliac patients.

Authors:  G Bruce; J F Woodley; C H Swan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

Review 3.  Coeliac syndrome: biochemical mechanisms and the missing peptidase hypothesis revisted.

Authors:  T J Peters; I Bjarnason
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

4.  Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals.

Authors:  S Friis; E Dabelsteen; H Sjöström; O Norén; S Jarnum
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

5.  In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease.

Authors:  H J Cornell; D E Rivett
Journal:  J Protein Chem       Date:  1995-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.